Kapar, C. Et Al. 2020. TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: WHAT ARE THE TRIGGERS OF DRUG-RELATED ADVERSE EFFECTS?. Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , (ELECTR NETWORK).

Kapar, C., Cavus, B., Atasoy, A., Suleymanova, V., Isik, A., Karahan, L., ... Cifcibasi, A. O.(2020). TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: WHAT ARE THE TRIGGERS OF DRUG-RELATED ADVERSE EFFECTS? . Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK

Kapar, Caner Et Al. "TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: WHAT ARE THE TRIGGERS OF DRUG-RELATED ADVERSE EFFECTS?," Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 2020

Kapar, Caner Et Al. "TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: WHAT ARE THE TRIGGERS OF DRUG-RELATED ADVERSE EFFECTS?." Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , ELECTR NETWORK, 2020

Kapar, C. Et Al. (2020) . "TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: WHAT ARE THE TRIGGERS OF DRUG-RELATED ADVERSE EFFECTS?." Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , ELECTR NETWORK.

@conferencepaper{conferencepaper, author={Caner KAPAR Et Al. }, title={TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: WHAT ARE THE TRIGGERS OF DRUG-RELATED ADVERSE EFFECTS?}, congress name={Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)}, city={}, country={ELECTR NETWORK}, year={2020}}